Saliva test upstart Rako Science sold to rival APHG

Saliva test upstart Rako Science sold to rival APHG
Rako Science partnered with Waipareira Trust to provide covid saliva testing for Māori. (Image: NZME)
Pattrick Smellie
Today’s announcement of the sale of saliva-testing firm Rako Science to what was once its arch-rival, Asia Pacific Healthcare Group (APHG), is a classic case of the old adage: “If you can’t beat 'em, join 'em”.For more than a year at the height of the covid lockdowns, Rako and APHG were at one another’s throats both in public and behind-the-scenes as Rako aggressively pressed the case for national uptake of its novel saliva test technology.Rako’s main target was the health ministry, which appeared to...

More Opinion

Finally, a small stand is made against Big Tech
Opinion

Peter Griffin: Finally, a small stand is made against Big Tech

However, we look set to repeat the errors of the Web 2.0 era.

Benchmark-beaters: how ESG gives indexers active power
Opinion

David Chaplin: Benchmark-beaters: how ESG gives indexers active power

The ESG push among institutional investors is changing the mix.

David Chaplin 03 Jul 2024
Has ArborGen finally crossed the Rubicon?
Opinion

Paul McBeth: Has ArborGen finally crossed the Rubicon?

Long-suffering shareholders might be dubious about the emerging green shoots.

Paul McBeth 02 Jul 2024
Our nation of tinkerers
Opinion

Simon Robertson: Our nation of tinkerers

From wine to Wētā, New Zealanders are always excelling at something.  

Simon Robertson 29 Jun 2024